Prescription drug · ANDA
Sucralfate NDC 68071-3478
Sucralfate 1 g/1 · Tablet · Oral · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-3478-3 | 6807134780368071347803 | 30 TABLET in 1 BOTTLE, PLASTIC (68071-3478-3)Marketed from Aug 3, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sucralfate
- Generic name (nonproprietary)
- sucralfate
- Active ingredients
- Sucralfate — 1 g/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NuCare Pharmaceuticals,Inc.NDC labeler code 68071
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074415
- Marketing start
- Listing expires
- Other FDA classes
- Organometallic Compounds (Chemical structure)
- Identifiers
- Product ID 68071-3478_2ad411ea-6bf6-b3bd-e063-6394a90af2e7SPL ID 2ad411ea-6bf6-b3bd-e063-6394a90af2e7SPL set ID 0206d7fa-a1d5-35d9-e063-6294a90a5eb3RxCUI 314234UNII XX73205DH5UPC 0368071347838
- Pharmacologic class
- Aluminum Complex
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071347803followed by a unit qualifier and the quantityPackage 68071-3478-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
Excerpt only. Read the full label for complete information.
About NDC 68071-3478
- What is NDC 68071-3478?
- 68071-3478 is the product NDC for Sucralfate, Sucralfate 1 g/1 tablet, listed with the FDA by NuCare Pharmaceuticals,Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sucralfate.
- What is the active ingredient?
- Sucralfate.
- Who is the labeler?
- NuCare Pharmaceuticals,Inc., NDC labeler code 68071. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sucralfate?
- 65 other product NDCs are listed under this name. See all Sucralfate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Sucralfate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Sucralfate | Sucralfate 1 g/10mL | SuspensionOral | Safecor Health, LLC | 48433-226 | 48433-0226-40 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Cardinal Health 107, LLC | 55154-0281 | 55154-0281-00 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Safecor Health LLC | 48433-091 | 48433-0091-20 |
| Sucralfate | Sucralfate 1 g/10mL | SuspensionOral | Torrent Pharmaceuticals Limited | 13668-754 | 13668-0754-42 |
| Sucralfate | Sucralfate 1 g/10mL | SuspensionOral | Chartwell RX, LLC | 62135-106 | 62135-0106-44 |
| Sucralfate | Sucralfate 1 g/10mL | SuspensionOral | Chartwell Governmental & Specialty RX, LLC | 68999-106 | 68999-0106-24 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Coupler LLC | 67046-1469 | 67046-1469-03 |
| Sucralfatesucralfate oral | Sucralfate 1 g/10mL | SuspensionOral | Precision Dose, Inc. | 68094-041 | 68094-0041-6168094-0041-62 |
| Sucralfate | Sucralfate 1 g/10mL | SuspensionOral | Cosette Pharmaceuticals, Inc. | 0713-0791 | 00713-0791-75 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Preferred Pharmaceuticals Inc | 68788-8779 | 68788-8779-0368788-8779-09 |
Other NDCs under ANDA 074415
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sucralfate | Sucralfate 1 g/1 | TabletOral | A-S Medication Solutions | 50090-6455 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Chartwell RX, LLC | 62135-436 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 63629-9152 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 63629-9153 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 71335-2114 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-541 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Bryant Ranch Prepack | 72162-2264 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Direct_Rx | 72189-429 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0188 |
| Sucralfate | Sucralfate 1 g/1 | TabletOral | Proficient Rx LP | 82804-102 |